$13.40
+0.0200 (+0.149%)
At Close: Jun 03, 2026
NEW YORK CITY, NY / ACCESS Newswire / May 19, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Organon & Co. ("Organon" or "the Company") (NYSE: O
Ongoing Investigation into Organon & Co. (OGN): Contact Levi & Korsinsky About Potential Fraud
05:16pm, Sunday, 18'th May 2025
NEW YORK, NY / ACCESS Newswire / May 18, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of Organon & Co. ("Organon & Co.") (NYSE:OGN) concerning possible violations
Levi & Korsinsky Investigates Organon & Co. (OGN) Over Possible Securities Fraud
10:09am, Sunday, 18'th May 2025
NEW YORK, NY / ACCESS Newswire / May 18, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of Organon & Co. ("Organon & Co.") (NYSE:OGN) concerning possible violations
NEW YORK CITY, NY / ACCESS Newswire / May 18, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Organon & Co. ("Organon" or "the Company") (NYSE: O
Shareholders Alert: Investigation Into Organon & Co. (OGN) - Contact Levi & Korsinsky to Protect Your Rights
10:15am, Friday, 16'th May 2025
NEW YORK, NY / ACCESS Newswire / May 16, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of Organon & Co. ("Organon & Co.") (NYSE:OGN) concerning possible violations
NEW YORK CITY, NY / ACCESS Newswire / May 16, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Organon & Co. ("Organon" or "the Company") (NYSE:OG
Levi & Korsinsky Launches Fraud Investigation on Behalf of Organon & Co. (OGN) Shareholders
10:30am, Thursday, 15'th May 2025
NEW YORK, NY / ACCESS Newswire / May 15, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of Organon & Co. ("Organon & Co.") (NYSE:OGN) concerning possible violations
NEW YORK CITY, NY / ACCESS Newswire / May 15, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Organon & Co. ("Organon" or "the Company") (NYSE: O
Levi & Korsinsky Investigates Organon & Co. (OGN) Over Possible Securities Fraud
09:20pm, Wednesday, 14'th May 2025
NEW YORK, NY / ACCESS Newswire / May 14, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of Organon & Co. ("Organon & Co.") (NYSE:OGN) concerning possible violations
Levi & Korsinsky Investigates Organon & Co. (OGN) Over Possible Securities Fraud
10:15am, Wednesday, 14'th May 2025
NEW YORK, NY / ACCESS Newswire / May 14, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of Organon & Co. ("Organon & Co.") (NYSE:OGN) concerning possible violations
Bronstein, Gewirtz & Grossman, LLC Is Investigating Organon & Co. (OGN) And Encourages Investors to Connect
10:00am, Wednesday, 14'th May 2025
NEW YORK CITY, NY / ACCESS Newswire / May 14, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Organon & Co. ("Organon" or "the Company") (NYSE: O
Organon & Co. (OGN) Investors with Losses are Urged to Contact Levi & Korsinsky to Discuss Their Rights
10:15am, Tuesday, 13'th May 2025
NEW YORK, NY / ACCESS Newswire / May 13, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of Organon & Co. ("Organon & Co.") (NYSE:OGN) concerning possible violations
Organon & Co: Cost Takeout Catalysts, Initiate Strong Buy
11:47am, Monday, 12'th May 2025
Initiate Strong Buy on Organon & Co. with $26.4 PT, driven by cost savings, Nexplanon momentum, and biosimilars diversification offsetting Established Brands LOE. Forecasted EPS of $4.00 (FY25; +20.1%
Organon & Co. Investigation Ongoing: Contact Levi & Korsinsky About Potential Securities Fraud Allegations - OGN
10:15am, Monday, 12'th May 2025
NEW YORK, NY / ACCESS Newswire / May 12, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of Organon & Co. ("Organon & Co.") (NYSE:OGN) concerning possible violations
NEW YORK CITY, NY / ACCESS Newswire / May 12, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Organon & Co. ("Organon" or "the Company") (NYSE: O
Sign In
Buy OGN